BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2064968)

  • 21. [Activation mechanism of neutrophil NADPH oxidase complex--molecular pathology of chronic granulomatous disease].
    Umeki S
    Tanpakushitsu Kakusan Koso; 1994 Nov; 39(14):2284-96. PubMed ID: 7809374
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular basis of chronic granulomatous disease.
    Smith RM; Curnutte JT
    Blood; 1991 Feb; 77(4):673-86. PubMed ID: 1993212
    [No Abstract]   [Full Text] [Related]  

  • 23. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.
    Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T
    J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sea-blue histiocyte syndrome: type B Niemann-Pick disease].
    González Reimers E; Alvarez Argüelles H; Hernández Nieto L; Beutler E; Alarcó Hernández A; Plasencia García V; Marsá Vilá L; Morales Rodríguez LP
    Med Clin (Barc); 1986 Apr; 86(15):644-6. PubMed ID: 3724278
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic granulomatous disease.
    Segal AW
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():195-8. PubMed ID: 2032145
    [No Abstract]   [Full Text] [Related]  

  • 26. A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase.
    Lew PD; Southwick FS; Stossel TP; Whitin JC; Simons E; Cohen HJ
    N Engl J Med; 1981 Nov; 305(22):1329-33. PubMed ID: 6270561
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease.
    Lomax KJ; Leto TL; Nunoi H; Gallin JI; Malech HL
    Science; 1989 Jul; 245(4916):409-12. PubMed ID: 2547247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of myeloid cell cytosols functionally and immunochemically deficient in the 47 kDa or 67 kDa NADPH oxidase cytosolic factors.
    Levy R; Malech HL; Rotrosen D
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1114-20. PubMed ID: 2167670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular and cellular pathology of chronic granulomatous disease.
    Segal AW
    Eur J Clin Invest; 1988 Oct; 18(5):433-43. PubMed ID: 2852593
    [No Abstract]   [Full Text] [Related]  

  • 30. NADPH:O2 oxidoreductase of human eosinophils in the cell-free system.
    Bolscher BG; Koenderman L; Tool AT; Stokman PM; Roos D
    FEBS Lett; 1990 Jul; 268(1):269-73. PubMed ID: 2384165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy.
    Gallin JI; Malech HL
    JAMA; 1990 Mar; 263(11):1533-7. PubMed ID: 2106591
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful pregnancy in a patient with familial sea-blue histiocyte syndrome.
    Fadilah SA; Mazeni NR; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):510-2. PubMed ID: 11221166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NADPH oxidase deficiency in X-linked chronic granulomatous disease.
    Hohn DC; Lehrer RI
    J Clin Invest; 1975 Apr; 55(4):707-13. PubMed ID: 235560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sea-blue histiocytes in a patient with mycosis fungoides].
    Allegue F; Soria C; Escribano L; Rocamora A; Moreno R; Ledo A
    Med Cutan Ibero Lat Am; 1990; 18(2):141-4. PubMed ID: 2214943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease.
    Vowells SJ; Fleisher TA; Sekhsaria S; Alling DW; Maguire TE; Malech HL
    J Pediatr; 1996 Jan; 128(1):104-7. PubMed ID: 8551399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic thrombocytopenic purpura associated with bone marrow sea-blue histiocytosis.
    Ganguly S; Cunningham MT
    Am J Hematol; 2004 Dec; 77(4):405-6. PubMed ID: 15558791
    [No Abstract]   [Full Text] [Related]  

  • 37. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.
    Segal AW
    J Clin Invest; 1989 Jun; 83(6):1785-93. PubMed ID: 2656760
    [No Abstract]   [Full Text] [Related]  

  • 38. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH; Gallin JI; Holland SM
    J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of NADPH oxidase activity in chronic granulomatous disease.
    McPhail LC; DeChatelet LR; Shirley PS; Wilfert C; Johnston RB; McCall CE
    J Pediatr; 1977 Feb; 90(2):213-7. PubMed ID: 12254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histiocytic diseases of bone marrow.
    Lee RE
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):657-67. PubMed ID: 3220804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.